Sukhani told CNBC-TV18, "Lupin is almost in a similar chart pattern as Divis Lab except that Lupin has not gone through a correction, it is making lifetime new highs. Similar because both of them are suggesting attractive buying opportunities, both of them are defensives. So for a stock that makes lifetime new highs, we want to go and buy it. Not necessarily in the morning itself but this doesn't stop, just like we have a talk of Apollo Tyres which is doing the same thing."
He further added, "You can have a one day pullback or a two days pullback but this upmove continues. So Lupin is something that we want to buy, simply because everyone is buying it and there is lot of strength in it."
Subscribe to:
Post Comments (Atom)
-
Lupin’s Q2FY17 revenues were in-line with our estimates. Revenues grew by 32% YoY to INR 42.1 bn (as compared to our estimate of INR 41.9 b...
-
GSK 2Q results were disappointing with 3% decline in MFD volumes amidst continuous pressure on discretionary spending by the consumers. ... -
Volume grew by 4.2% QoQ, best in last 12 quarters. The company expects strong volume momentum to continue despite the mixed view on clie...
No comments:
Post a Comment